DOI:
10.1055/s-00000005
Aktuelle Rheumatologie
LinksClose Window
References
Braun J, Baraliakos X, Hermann KG. et al.
Effect of certolizumab pegol over 96 weeks of treatment on inflammation of the spine and sacroiliac joints, as measured by MRI, and the association between clinical and MRI outcomes in patients with axial spondyloarthritis.
RMD open 2017;
3: e000430. doi:10.1136/rmdopen-2017-000430
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.